European Orthopedic Biomaterials Market:

The orthopedic biomaterials market is highly variable throughout Europe, and is strongly affected by different national regulations and reimbursement structures. The materials consist of devices and products that are either biologically derived, capable of producing a regenerative response beyond that of normal healing, or absorbed by the body during the healing process.

The European orthopedic biomaterials market includes

  • bone graft substitutes (BGS)
  • hyaluronic acid (HA) viscosupplementation
  • bone morphogenetic protein (BMP) growth factor therapy and
  • autologous chondrocyte implantation (ACI).

Largest Segment:The Hyaluronic Acid (HA) Viscosupplementation Market
Fastest Growing Segment: The Autologous Chondrocyte Implantation (ACI) Market: CAGR of 11.4% by 2019

 

United States Orthopedic Biomaterials Market:

The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems. Conversely, some products that previously experienced rapid market growth has now entered maturity, but even these markets are sustained by continued product evolution.

This comprehensive report critically examines the following market segments:

  • bone graft substitutes
  • growth factors
  • orthopedic stem cells
  • cell therapy
  • hyaluronic acid viscosupplementation
  • tendon grafts
  • cartilage repair and
  • spinal machined bone allografts.

Largest Segment: Bone Graft Substitute (BGS): 1,374,006 procedures
Fastest Growing Segment: Orthopedic Stem Cell Market

U.S. United States and European Orthopedic Biomaterials Market Overview

 

Companies included in this report are:

US: Medtronic, Orthofix, Fidia, Bioventus, Depuy Synthes, Stryker, Biomet, Ferring Pharmaceuticals, AlloSource, Exactech, Anika Therapeutics, LifeNet Health, RTI Biologics, Harvest Technologies, Biotech, Celling Biosciences, AlloSource, NuVasive, Musculoskeletal Transplant Foundation, etc.

Europe: Zimmer, Biomet, TiGenix, Depuy Synthes, Olympus, Wright Medical, Smith & Nephew, Seikagaku, Tedec-Meiko, Fin-Ceramica, Croma-Pharma, Laboratorie Genevrier, TRB Chemedica, Genzyme, Fidia and RottaPharm.

For a full list of sub-segments and a free synopsis of the U.S. Report ; European Report.